MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

153.38 -1.09 (-0.71%)
Official Closing Price Updated: 7:00 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,260,526
Open 154.04
Bid (Size) 152.51 (100)
Ask (Size) 160.74 (100)
Prev. Close 154.47
Today's Range 153.33 - 155.04
52wk Range 104.93 - 170.46
Shares Outstanding N/A
Dividend Yield 2.60%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
Big Pharma Deepens AI Ties. What It Means For Novo, Novartis. ↗
Novo Nordisk and Novartis deepened their ties to AI companies on Tuesday. And they won't be the last pharma giants to do so. 
Via Investor's Business Daily
Topics Artificial Intelligence

Performance

YTD
+10.7%
+10.7%
1 Month
-1.0%
-1.0%
3 Month
+8.2%
+8.2%
6 Month
+18.8%
+18.8%
1 Year
+40.1%
+40.1%

More News

Read More
News headline image
The Radiopharmaceutical Renaissance: A Deep Dive into Telix Pharmaceuticals (TLX)
Via Finterra
Topics Economy Initial Public Offering
Novartis AG-Sponsored ADR (NYSE:NVS) Presents a Compelling Case for Dividend Investors ↗
Via Chartmill
Novartis AG-Sponsored ADR (NYSE:NVS): A Methodical Pick for Steady Dividend Income ↗
Via Chartmill
News headline image
3 Low-Volatility ETFs for Peace of Mind in Turbulent Times ↗
Via MarketBeat
Topics ETFs
News headline image
The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports
Via MarketMinute
Topics Economy World Trade
News headline image
Trump Issues Landmark Executive Order: 100% Tariffs on Imported Patented Drugs to Force Onshoring
Via MarketMinute
Topics Economy Government Lawsuit
News headline image
Legend Biotech (LEGN) Q4 2024 Earnings Transcript ↗
Via The Motley Fool
Topics Earnings Economy World Trade
News headline image
Legend Biotech (LEGN) Q1 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Biogen's $5.6 Billion Acquisition of Apellis: A Strategic Pivot into Rare Kidney Diseases
Via MarketMinute
News headline image
Could Investing $10,000 in VYMI Make You a Millionaire? ↗
Via The Motley Fool
Topics ETFs Stocks
News headline image
Novartis Bets $2 Billion To Deepen Allergy Drug Pipeline ↗
Via Benzinga
News headline image
International ETFs: EEM and IEFA Offer Distinct Global ETF Choices ↗
Via The Motley Fool
Topics ETFs
News headline image
Sarepta Therapeutics (SRPT) Stock Surges 34.98% on Breakthrough Clinical Data
Via MarketMinute
News headline image
The Second Act: A Deep-Dive into Corcept Therapeutics and the FDA Approval of Lifyorli
Via Finterra
Topics Economy Intellectual Property
News headline image
The $6.7 Billion Pivot: A Deep Dive into Terns Pharmaceuticals (TERN) and the Merck Acquisition
Via Finterra
Topics Initial Public Offering Intellectual Property World Trade
News headline image
Retirees: Collect a High Dividend While Diversifying Your Portfolio With This ETF ↗
Via The Motley Fool
Topics ETFs Retirement
News headline image
3 ETFs Built for the Volatile Market We're Seeing in March 2026 ↗
Via The Motley Fool
Topics ETFs Economy Stocks
News headline image
Novartis Strikes $3 Billion Deal For Next-Gen Breast Cancer Drug ↗
Via Benzinga
News headline image
The High-Stakes Gambit: How Healthcare Giants are 'Front-Loading' Megadeals to Outrun Regulatory Storms
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
News headline image
Novartis Advances Dermatology Portfolio With Cosentyx FDA Approval For Pediatric Patients ↗
Via Benzinga
News headline image
VYMI: This International ETF Could Help You Earn Higher Dividends ↗
Via The Motley Fool
Topics ETFs
News headline image
3 ETFs to Avoid as Oil Shock Hits Markets ↗
Via MarketBeat
Topics ETFs
News headline image
Vertex Pharmaceuticals Surges as Breakthrough Kidney Data Sets New Gold Standard for IgA Nephropathy
Via MarketMinute

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 153.38
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 04/14/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story